Crystallization (Comment) | Organism |
---|---|
purified Srx-Prx1 complex, hanging drop vapor diffusion method, mixing of 10 mg/ml protein in 20 mM HEPES, pH 7.5, 100 mM NaCl with well solution containing 100 mM citric acid, pH 4.5, 26% PEG 400, and 100 mM CsCl, X-ray diffraction structure determination and analysis at 3.0 A resolution, molecular replacement and modeling by superimposing five dimeric Srx-Prx1 complexes (PDB entry 2RII) onto the five Prx dimers within the decameric Prx2-SO2H (PDB ID 1QMV) structure. The entire active site helix of Prx1 (residues 46-69) and the C-terminus (residues 169-199) are removed from the search model to reduce bias. Two decamers, each containing ten Prx and ten Srx molecules (five Prx dimers and ten Srx monomers), are found in the asymmetric unit, consistent with the observed self-rotation function. Additional crystallization of hyperoxidized Prx2 and Prx3 variants | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
additional information | Srx mutant variants analyzed by circular dichroism spectroscopy (JASCO-720) in 20 mM HEPES, pH 7.5, 100 mM NaCl at a concentration from 0.4 mg/ml are confirmed to exhibit wild-type-like spectra | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Homo sapiens |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 R-SH | Homo sapiens | - |
peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + R-S-S-R | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q9BYN0 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | specificity of human sulfiredoxin for reductant and peroxiredoxin oligomeric state, overview. The resolution of the Prx-Srx complex involves the reduction of the thiosulfinate intermediate (Prx-CP-S=O-S-Srx) to yield the Prx Cys-sulfenic acid intermediate (Prx-CP-SOH). Yeast Srx contains an adjacent resolving Cys residue (Cys-SR) that can react with the thiosulfinate intermediate leading to the formation of an Srx intramolecular disulfide (Srx-(S-S)). In contrast, human Srx has only one Cys residue and requires an exogenous reductant. Possible reductants include the Trx system (Trx/TrxR/NADPH), glutathione (GSH) and hydrogen sulfide (H2S), these reductants would ultimately yield reduced Srx (Srx-SH). Enzyme-substrate binding studies with mutant Prx1 (e.g. Prx1 C83V and Prx1 C71S/C173S). Repair of hyperoxidized Prx2, Prx3 and their chimeras, the C-terminal sequence differences between Prx2 and Prx3 impact the rate of repair by Srx | Homo sapiens | ? | - |
- |
|
peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 DTT | - |
Homo sapiens | peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + DTT disulfide | - |
? | |
peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 GSH | combined GSH and H2S for the repair of cytosolic Prx2 | Homo sapiens | peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + G-S-S-G | - |
? | |
peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 H2S | preference for H2S to support the repair of mitochondrial hyperoxidized Prx3 by Srx. Combined GSH and H2S for the repair of cytosolic Prx2 | Homo sapiens | peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + HS-SH | - |
? | |
peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 R-SH | - |
Homo sapiens | peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + R-S-S-R | - |
? | |
peroxiredoxin-(S-hydroxy-S-oxocysteine) + ATP + 2 R-SH | hyperoxidized Prx1 | Homo sapiens | peroxiredoxin-(S-hydroxycysteine) + ADP + phosphate + R-S-S-R | - |
? |
Subunits | Comment | Organism |
---|---|---|
More | the decameric Srx-Prx1 complex reveals extended binding interface, human Prx1 and Prx2 form a decameric toroid | Homo sapiens |
Synonyms | Comment | Organism |
---|---|---|
Srx | - |
Homo sapiens |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Homo sapiens |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
7.5 | - |
assay at | Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | loss of the extended active site interface within engineered peroxiredoxin isozymes, Prx2 and Prx3, dimers yields variants more resistant to hyperoxidation and repair by enzyme Srx | Homo sapiens |
additional information | the decameric Srx-Prx1 complex reveals extended binding interface, human Prx1 and Prx2 form a decameric toroid. The crystal structure of the toroidal Prx1-Srx complex shows an extended active site interface. Structural basis for the ability of Srx to reduce the hyperoxidized form of human Prxs, juxtaposition of the two active-site interfaces of the two proteins and wrapping of the Prx C-terminus around Srx in an essential interaction, overview | Homo sapiens |
physiological function | the repair and reactivation of the hyperoxidized Prxs by Srx is an important cellular process, hydrogen sulfide repair of hyperoxidized 2-Cys Prxs by human sulfiredoxin (Srx), structural requirements, peroxiredoxin catalytic and sulfiredoxin repair cycles, detailed overview. The physiological reductants hydrogen sulfide (H2S) and glutathione (GSH) show relative efficacy in this reaction. Prx isoform-dependent use of and potential cooperation between GSH and H2S in supporting Srx activity | Homo sapiens |